Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Atlantic Securities from a "neutral" rating to an "overweight" rating. They now have a $144.00 price targe
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Hosts Conference Call for First-Quarter EarningsPR Newswire
- 2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income [Yahoo! Finance]Yahoo! Finance
- ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) Receives FDA Approval For Coronary IVL System Trial In US [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 1/22/25 - In-Line
ABT
Sec Filings
- 3/14/25 - Form ARS
- 3/14/25 - Form DEFA14A
- 3/14/25 - Form DEF
- ABT's page on the SEC website